![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web |
Hepatitis C |
Free Subscription
1 Dig Dis Sci |
Retrieve available abstracts of this week’s articles:
HTML format Text format |
Single Articles |
AMEDEO Hepatitis C is free of charge.
New Face of Hepatitis C.
Dig Dis Sci. 2019 Feb 13. pii: 10.1007/s10620-019-05511.
PubMed
Text format
Abstract available
A central hydrophobic E1 region controls the pH range of hepatitis C virus
membrane fusion and susceptibility to fusion inhibitors.
J Hepatol. 2019 Feb 12. pii: S0168-8278(19)30110.
PubMed
Text format
Abstract available
ERAP1 allotypes impact the epitope repertoire of virus-specific CD8(+) T cell
responses in acute hepatitis C virus infection.
J Hepatol. 2019 Feb 12. pii: S0168-8278(19)30111.
PubMed
Text format
Abstract available
Changing trends in international versus domestic HCV transmission in HIV-positive
MSM: A perspective for the DAA scale-up era.
J Infect Dis. 2019 Feb 13. pii: 5318573. doi: 10.1093.
PubMed
Text format
Abstract available
Frequency and Implications of Myeloid Derived Suppressor Cells and Lymphocyte
Subsets in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular
Carcinoma.
J Med Virol. 2019 Feb 13. doi: 10.1002/jmv.25428.
PubMed
Text format
Abstract available
Vitamin D deficiency and health-related quality of life in chronic hepatitis C.
J Viral Hepat. 2019 Feb 9. doi: 10.1111/jvh.13076.
PubMed
Text format
Abstract available
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir +/-
dasabuvir +/- ribavirin in hepatitis C virus genotype 1- and 4-infected patients
with diverse comorbidities and comedications: A pooled analysis of post-marketing
observation
J Viral Hepat. 2019 Feb 10. doi: 10.1111/jvh.13080.
PubMed
Text format
Abstract available
Efficacy and Safety of Ruzasvir 60 mg and Uprifosbuvir 450 mg for 12 Weeks in
Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection.
J Viral Hepat. 2019 Feb 9. doi: 10.1111/jvh.13079.
PubMed
Text format
Abstract available
Low recurrence rate of hepatocellular carcinoma following ledipasvir and
sofosbuvir treatment in a real-world chronic hepatitis C patients cohort.
J Viral Hepat. 2019 Feb 11. doi: 10.1111/jvh.13075.
PubMed
Text format
Abstract available
Clinical outcomes in patients with chronic hepatitis C after direct-acting
antiviral treatment: a prospective cohort study.
Lancet. 2019 Feb 11. pii: S0140-6736(18)32111.
PubMed
Text format
Abstract available
Direct-acting antiviral treatment for hepatitis C.
Lancet. 2019 Feb 11. pii: S0140-6736(18)32326.
PubMed
Text format
Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to
Hepatitis C.
N Engl J Med. 2019;380:607-610.
PubMed
Text format
Brazil's Fight against Hepatitis C - Universalism, Local Production, and Patents.
N Engl J Med. 2019;380:605-607.
PubMed
Text format
Combining liver stiffness with hyaluronic acid provides superior prognostic
performance in chronic hepatitis C.
PLoS One. 2019;14:e0212036.
PubMed
Text format
Abstract available
A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis
C virus infection in the era of direct-acting antivirals?
PLoS One. 2019;14:e0211795.
PubMed
Text format
Abstract available
Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis
seroprevalence among female prisoners in Indonesia: A cross-sectional study.
PLoS One. 2019;14:e0207970.
PubMed
Text format
Abstract available
Reaching the WHO target of testing persons in jails in prisons will need diverse
efforts and resources.
PLoS One. 2018;13:e0202985.
PubMed
Text format
Abstract available
Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase.
Virology. 2019;529:226-233.
PubMed
Text format
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by